See also this year's filing and all EDGAR filings for this company.
PDF Report 0000886163_2012_Ligand_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0000886163, Ligand Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 32,230,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 72,331,000 |
| 2 | PropertyPlantAndEquipmentNet | 455,000 |
| 3 | remainder_Assets | 17,334,000 |
| 4 | LiabilitiesCurrent | 43,643,000 |
| 5 | LiabilitiesNoncurrent | 388,000 |
| 6 | remainder_Liabilities | 61,329,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,977,000 |
| 9 | ResearchAndDevelopmentExpense | 10,291,000 |
| 10 | remainder_Expenses | -5,956,000 |
| 11 | remainder_Revenues | 30,037,000 |
| 12 | remainder_NetIncome | -549,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 122,350,000 |
| 1 | Liabilities | 105,360,000 |
| 2 | Expenses | 19,312,000 |
| 3 | Revenues | 30,037,000 |
| 4 | StockholdersEquity | 16,990,000 |
| 5 | NetIncome | 10,176,000 |
| 6 | ComprehensiveNetIncome | 10,176,000 |
| 7 | BaseVar | 138,804,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.415 |
| 9 | EconomicCapitalRatio | 1.81 |
Edgar->Model Mapping
Feature Distribution
